Shareholder Information

Top 10 Largest Shareholders

(As of September 30,2025)

Name of shareholder Number of shares held（thousands) Percentage of shares held（％）
Master Trust Bank of Japan, Ltd. (Trust Account) 2,910 10.24
NIPPON ACTIVE VALUE FUND PLC 2,399 8.44
Takeda Pharmaceutical Company Limited 2,204 7.76
Zeria Pharmaceutical Co., Ltd. 1,877 6.61
STATE STREET BANK AND TRUST COMPANY 505103 1,147 4.04
MUFG Bank, Ltd.
 1,100 3.87
NAVF SELECT LLC 848 2.98
Takashi Yamaguchi 707 2.49
CACEIS BANK, LUXEMBOURG BRANCH/AIF CLIENTS ASSETS 593 2.08
Kabushiki Kaisha YAMAGUCHI
 579 2.04
Note 
  • Percentage of shares held is based on the number of shares exclusive of treasury shares.

Status of Shares

Distribution of Shareholders

Share Unit Distribution

Number Of Shareholders

Highest/Lowest Share Price

Capital and Issued Shares

　　
Capital Issued shares
April 1, 2021 ¥1,197.9 million 30,563,199 shares
March 31, 2022 ¥1,197.9 million 30,563,199 shares
March 31, 2023 ¥1,197.9 million 30,563,199 shares
March 31, 2024 ¥1,197.9 million 30,563,199 shares
March 31, 2025 ¥1,197.9 million 28,763,199 shares

Notes: In April 2021, through a sole-share transfer, the Company was established as the wholly owned parent company of ASKA Pharmaceutical Co. Ltd.

Status of Treasury Stock

Information regarding the acquisition and cancellation/disposal of treasury stock is provided below.

Number of shares acquired (shares) Number of shares cancelled/disposed (shares)
August 13, 2025 ー 32,700
March 21, 2025 ー 1,800,000
August 15, 2024 ー 34,700
August 9, 2023 ー 37,300
August 10, 2022 ー 52,400
March 1 to March 23, 2022 90,000 ー
February 1 to February 28, 2022 91,000 ー
January 1 to January 31, 2022 59,000 ー
December 1 to December 31, 2021 20,000 ー
August 1 to August 31, 2021 40,000 ー
August 11, 2021 ー 52,300

Stock Split

The Company has not conducted any stock splits within the past five years.